Rajan Sharma
Stock Analyst at Goldman Sachs
(0.06)
# 4,501
Out of 5,140 analysts
5
Total ratings
25%
Success rate
-44.89%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rajan Sharma
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Reinstates: Sell | $7.25 | $21.41 | -66.13% | 1 | May 29, 2025 | |
| AZN AstraZeneca | Initiates: Buy | $97 | $204.20 | -52.50% | 1 | May 30, 2024 | |
| GSK GSK plc | Initiates: Neutral | $47 | $59.52 | -21.03% | 1 | May 30, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Overweight | $79 | $32.75 | +141.22% | 2 | Jun 20, 2023 |
DBV Technologies
May 29, 2025
Reinstates: Sell
Price Target: $7.25
Current: $21.41
Upside: -66.13%
AstraZeneca
May 30, 2024
Initiates: Buy
Price Target: $97
Current: $204.20
Upside: -52.50%
GSK plc
May 30, 2024
Initiates: Neutral
Price Target: $47
Current: $59.52
Upside: -21.03%
Immunocore Holdings
Jun 20, 2023
Reiterates: Overweight
Price Target: $79
Current: $32.75
Upside: +141.22%